TGen s Spyro Mousses on Using RNAi to Advance Cancer Drug Research | GenomeWeb

At A Glance

Name: Spyro Mousses

Position: Director, Cancer Drug Development Laboratory, Translational Genomics Research Institute

Background: Staff scientist, National Human Genome Research Institute — 2002; Senior research fellow, NHGRI — 2001-2002; Postdoc, NHGRI — 1998-2001; PhD, cancer genetics, University of Toronto — 1998; MS, cancer genetics, University of Toronto — 1994; BS, pharmacology/toxicology, University of Toronto — 1991

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.